PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F15EY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $15,984
Award facts
- Contract value 100% obligated
- $15,984.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a $15,984 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on January 23, 2026, with an ultimate completion date of January 26, 2026. This contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999.999 billion through December 2026. The award was competitively made with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the overarching $999.999 billion IDC with DLA Troop Support Medical that extends through December 2031, positioning the organization as a primary global pharmaceutical support vehicle for military healthcare programs worldwide. This structure enables efficient delivery of essential medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The DLA Medical Supply Chain is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, indicating AmerisourceBergen's continued strategic importance in federal pharmaceutical procurement alongside other potential contractors.
Quick answers
Who was awarded contract SPE2D826F15EY?
SPE2D826F15EY was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 23, 2026.
How much is contract SPE2D826F15EY worth?
The government has obligated $15,984 on SPE2D826F15EY.
Is contract SPE2D826F15EY an order under another contract?
Yes. SPE2D826F15EY is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F15EY competed?
The extent of competition for SPE2D826F15EY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award